All Stories

  1. The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population

    Article • Journal of Human Genetics, February 2024, Springer Science + Business Media

    Masashi Idogawa

  2. Long Noncoding RNA RP11-278A23.1, a Potential Modulator of p53 Tumor Suppression, Contributes to Colorectal Cancer Progression

    Article • Cancers, February 2024, MDPI AG

    Masashi Idogawa

  3. The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.

    Article • August 2023, Research Square

    Masashi Idogawa

  4. MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway

    Article • BMC Cancer, January 2023, Springer Science + Business Media

    Masashi Idogawa

  5. Downregulation of protein kinase C gamma reduces epithelial property and enhances malignant phenotypes in colorectal cancer cells

    Article • iScience, December 2022, Elsevier

    Masashi Idogawa

  6. Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy

    Article • Medical Molecular Morphology, November 2022, Springer Science + Business Media

    Masashi Idogawa

  7. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells

    Article • Biochemical and Biophysical Research Communications, November 2022, Elsevier

    Masashi Idogawa

  8. Impact of sensitive circulating tumor DNA monitoring on CT scan intervals during postoperative colorectal cancer surveillance

    Article • September 2022, Cold Spring Harbor Laboratory Press

    Masashi Idogawa

  9. Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

    Article • Hepatology, June 2022, Wolters Kluwer Health

    Masashi Idogawa

  10. Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations

    Article • Experimental Cell Research, April 2022, Elsevier

    Masashi Idogawa

  11. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma

    Article • Cancer Medicine, March 2022, Wiley

    Masashi Idogawa

  12. Estimation of the true infection rate and infection fatality rate of coronavirus disease 2019 in each country

    Article • Journal of Infection and Public Health, February 2022, Elsevier

    Masashi Idogawa

  13. BHLHE41/DEC2 Expression Induces Autophagic Cell Death in Lung Cancer Cells and Is Associated with Favorable Prognosis for Patients with Lung Adenocarcinoma

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Masashi Idogawa

  14. Functional Depletion of HSP72 by siRNA and Quercetin Enhances Vorinostat-Induced Apoptosis in an HSP72-Overexpressing Cutaneous T-Cell Lymphoma Cell Line, Hut78

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Masashi Idogawa

  15. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes

    Article • Scientific Reports, October 2021, Springer Science + Business Media

    Masashi Idogawa

  16. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer

    Article • Carcinogenesis, September 2021, Oxford University Press (OUP)

    Masashi Idogawa

  17. Dead or alive? Pitfall of survival analysis with TCGA datasets

    Article • Cancer Biology & Therapy, September 2021, Taylor & Francis

    Masashi Idogawa

  18. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS‐mutated sebaceous nevus

    Article • The Journal of Dermatology, April 2021, Wiley

    Masashi Idogawa

  19. ALK-positive atypical Spitz tumour with conspicuous rosette-like structures

    Article • European Journal of Dermatology, April 2021, John Libbey Eurotext

    Masashi Idogawa

  20. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Masashi Idogawa

  21. Correlation between PCR Examination Rate among the Population and the Containment of Pandemic of COVID-19

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Masashi Idogawa

  22. Interactive Web-based Graphs of Coronavirus Disease 2019 Cases and Deaths per Population by Country

    Article • Clinical Infectious Diseases, April 2020, Oxford University Press (OUP)

    Masashi Idogawa

  23. Genetic analyses of mosaic neurofibromatosis type 1 with giant café‐au‐lait macule, plexiform neurofibroma and multiple melanocytic nevi

    Article • The Journal of Dermatology, April 2020, Wiley

    Masashi Idogawa

  24. Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH)

    Article • Cancer Biology & Therapy, December 2019, Taylor & Francis

    Masashi Idogawa

  25. p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53

    Article • Oncogene, December 2019, Springer Science + Business Media

    Dr Yasushi Sasaki, Masashi Idogawa

  26. Corrigendum to “Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer”

    Article • Journal of Oncology, August 2019, Hindawi Publishing Corporation

    Masashi Idogawa

  27. Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer

    Article • Journal of Oncology, May 2019, Hindawi Publishing Corporation

    Dr Yasushi Sasaki, Masashi Idogawa

  28. High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme

    Article • British Journal of Cancer, March 2019, Springer Science + Business Media

    Masashi Idogawa

  29. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma

    Article • Tumor Biology, August 2018, SAGE Publications

    Dr Yasushi Sasaki, Masashi Idogawa

  30. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1

    Article • Cell Death and Disease, August 2018, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  31. HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors

    Article • Journal of Dermatological Science, April 2018, Elsevier

    Masashi Idogawa

  32. Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53

    Article • Cancer Science, November 2017, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  33. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing

    Article • Oncotarget, July 2017, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  34. Fledglings in p53 signaling network

    Article • Oncotarget, July 2017, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  35. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN

    Article • Cancer Letters, April 2017, Elsevier

    Masashi Idogawa, Dr Yasushi Sasaki

  36. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function

    Article • International Journal of Cancer, March 2017, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  37. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target

    Article • Oncotarget, August 2016, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  38. CRKL oncogene is downregulated by p53 through miR‐200s

    Article • Cancer Science, July 2015, Wiley

    Masashi Idogawa, Dr Yasushi Sasaki

  39. Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model

    Article • Journal of Gastroenterology, February 2015, Springer Science + Business Media

    Masashi Idogawa

  40. Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells

    Article • Oncotarget, July 2014, Impact Journals, LLC

    Masashi Idogawa, Dr Yasushi Sasaki

  41. Mesenchymal Stem Cells Cancel Azoxymethane-Induced Tumor Initiation

    Article • Stem Cells, March 2014, Wiley

    Masashi Idogawa

  42. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites

    Article • Human Molecular Genetics, January 2014, Oxford University Press (OUP)

    Masashi Idogawa, Dr Yasushi Sasaki

  43. Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors

    Article • Journal of Gastroenterology, November 2013, Springer Science + Business Media

    Masashi Idogawa

  44. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness

    Article • Oncogene, November 2013, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  45. AKR1B10, a Transcriptional Target of p53, Is Downregulated in Colorectal Cancers Associated with Poor Prognosis

    Article • Molecular Cancer Research, October 2013, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  46. CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion

    Article • Cancer Biology & Therapy, December 2012, Taylor & Francis

    Masashi Idogawa, Dr Yasushi Sasaki

  47. A novel approach to cancer treatment using structural hybrids of the p53 gene family

    Article • Cancer Gene Therapy, September 2012, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  48. CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation

    Article • Journal of Biological Chemistry, February 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Masashi Idogawa, Dr Yasushi Sasaki

  49. p53 Negatively Regulates the Hepatoma Growth Factor HDGF

    Article • Cancer Research, October 2011, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  50. A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth

    Article • BMC Cancer, June 2009, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  51. A Single Recombinant Adenovirus Expressing p53 and p21-targeting Artificial microRNAs Efficiently Induces Apoptosis in Human Cancer Cells

    Article • Clinical Cancer Research, May 2009, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  52. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB

    Article • Oncogene, May 2009, Springer Science + Business Media

    Masashi Idogawa, Dr Yasushi Sasaki

  53. p53 Family Members Regulate the Expression of the Apolipoprotein D Gene

    Article • Journal of Biological Chemistry, November 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Masashi Idogawa, Dr Yasushi Sasaki

  54. Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models

    Article • Molecular Cancer Therapeutics, April 2008, American Association for Cancer Research (AACR)

    Masashi Idogawa, Dr Yasushi Sasaki

  55. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors

    Article • Carcinogenesis, August 2007, Oxford University Press (OUP)

    Masashi Idogawa, Dr Yasushi Sasaki

  56. Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines

    Article • Cancer Biology & Therapy, July 2007, Taylor & Francis

    Masashi Idogawa, Dr Yasushi Sasaki

  57. Involvement of Splicing Factor-1 in β-Catenin/T-Cell Factor-4-Mediated Gene Transactivation and Pre-mRNA Splicing

    Article • Gastroenterology, March 2007, Elsevier

    Masashi Idogawa

  58. Ku70 and Poly(ADP-Ribose) Polymerase-1 Competitively Regulate β-Catenin and T-Cell Factor-4–Mediated Gene Transactivation: Possible Linkage of DNA Damage Recognition and Wnt Signaling

    Article • Cancer Research, February 2007, American Association for Cancer Research (AACR)

    Masashi Idogawa

  59. E-Cadherin Regulates the Association between β-Catenin and Actinin-4

    Article • Cancer Research, October 2005, American Association for Cancer Research (AACR)

    Masashi Idogawa

  60. β-Catenin Interacts With the FUS Proto-oncogene Product and Regulates Pre-mRNA Splicing

    Article • Gastroenterology, October 2005, Elsevier

    Masashi Idogawa

  61. Poly(ADP-Ribose) Polymerase-1 Is a Component of the Oncogenic T-Cell Factor-4/β-Catenin Complex

    Article • Gastroenterology, June 2005, Elsevier

    Masashi Idogawa

  62. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin protein

    Article • Oncogene, February 2005, Springer Science + Business Media

    Masashi Idogawa

  63. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer

    Article • Gastroenterology, January 2005, Elsevier

    Masashi Idogawa

  64. Alternative splice variant of actinin-4 in small cell lung cancer

    Article • Oncogene, May 2004, Springer Science + Business Media

    Masashi Idogawa

  65. Overexpression of BAD preferentially augments anoikis

    Article • International Journal of Cancer, August 2003, Wiley

    Masashi Idogawa

  66. A Case of aseptic osteomyelitis with heel ulcer improved by steroid application.

    Article • Japanese Journal of Clinical Immunology, January 2000, Japan Society for Clinical Immunology

    Masashi Idogawa

  67. A Case of Thymoma and Hypogammaglobulinemia(Good's syndrome) with Lichen planus.

    Article • Japanese Journal of Clinical Immunology, January 1999, Japan Society for Clinical Immunology

    Masashi Idogawa